United States · FDA National Drug Code directory
ZYMFENTRA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72606-047_e81d34f1-0902-43ef-ab88-470bcc6c0544
- Product NDC
- 72606-047
- Form
- INJECTION
- Composition / generic term
- infliximab-dyyb
- Labeler
- CELLTRION USA Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20240301
- Source listing expiry
- 20271231
Source-listed ingredients
- INFLIXIMAB-DYYB — 120 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (72606-047-01) / 1 mL in 1 SYRINGE · 72606-047-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →